109 related articles for article (PubMed ID: 16823853)
1. Oral contraceptive and IUD use and endometrial cancer: a population-based case-control study in Shanghai, China.
Tao MH; Xu WH; Zheng W; Zhang ZF; Gao YT; Ruan ZX; Cheng JR; Gao J; Xiang YB; Shu XO
Int J Cancer; 2006 Nov; 119(9):2142-7. PubMed ID: 16823853
[TBL] [Abstract][Full Text] [Related]
2. Intrauterine device use and endometrial cancer risk.
Sturgeon SR; Brinton LA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Lurain JR
Int J Epidemiol; 1997 Jun; 26(3):496-500. PubMed ID: 9222773
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptive use and risk of diabetes among Chinese women.
Rosenthal AD; Shu XO; Jin F; Yang G; Elasy TA; Li Q; Xu HX; Gao YT; Zheng W
Contraception; 2004 Mar; 69(3):251-7. PubMed ID: 14969675
[TBL] [Abstract][Full Text] [Related]
4. Intrauterine device use and risk of endometrial cancer.
Parazzini F; La Vecchia C; Moroni S
Br J Cancer; 1994 Oct; 70(4):672-3. PubMed ID: 7917915
[TBL] [Abstract][Full Text] [Related]
5. Contraceptive methods and risk of pelvic endometriosis.
Parazzini F; Ferraroni M; Bocciolone L; Tozzi L; Rubessa S; La Vecchia C
Contraception; 1994 Jan; 49(1):47-55. PubMed ID: 8137625
[TBL] [Abstract][Full Text] [Related]
6. Menstrual and reproductive factors and endometrial cancer risk: Results from a population-based case-control study in urban Shanghai.
Xu WH; Xiang YB; Ruan ZX; Zheng W; Cheng JR; Dai Q; Gao YT; Shu XO
Int J Cancer; 2004 Feb; 108(4):613-9. PubMed ID: 14696129
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of intrauterine device use and risk of endometrial cancer.
Beining RM; Dennis LK; Smith EM; Dokras A
Ann Epidemiol; 2008 Jun; 18(6):492-9. PubMed ID: 18261926
[TBL] [Abstract][Full Text] [Related]
8. Oral contraceptives and endometrial cancer.
Jick SS; Walker AM; Jick H
Obstet Gynecol; 1993 Dec; 82(6):931-5. PubMed ID: 8233267
[TBL] [Abstract][Full Text] [Related]
9. Oral contraceptive use and risk of colorectal cancer.
Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
[TBL] [Abstract][Full Text] [Related]
10. [Cancers of the uterus and ovary and the contraceptive pill].
Vessey MP
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):339-43. PubMed ID: 12280204
[TBL] [Abstract][Full Text] [Related]
11. IUD use and the risk of endometrial cancer.
Benshushan A; Paltiel O; Rojansky N; Brzezinski A; Laufer N
Eur J Obstet Gynecol Reprod Biol; 2002 Nov; 105(2):166-9. PubMed ID: 12381481
[TBL] [Abstract][Full Text] [Related]
12. Effect of adiposity and fat distribution on endometrial cancer risk in Shanghai women.
Xu WH; Matthews CE; Xiang YB; Zheng W; Ruan ZX; Cheng JR; Gao YT; Shu XO
Am J Epidemiol; 2005 May; 161(10):939-47. PubMed ID: 15870158
[TBL] [Abstract][Full Text] [Related]
13. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group.
Brinton LA; Hoover RN
Obstet Gynecol; 1993 Feb; 81(2):265-71. PubMed ID: 8380913
[TBL] [Abstract][Full Text] [Related]
14. Researchers can now investigate long-term effects of OCs on cancer.
Rubin GL; Peterson HB
Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
[TBL] [Abstract][Full Text] [Related]
15. Neoplastic effects of oral contraceptives.
Grimes DA
Int J Fertil; 1991; 36 Suppl 1():19-24. PubMed ID: 1678377
[TBL] [Abstract][Full Text] [Related]
16. Endometrial cancer in relation to intra-uterine device use.
Hill DA; Weiss NS; Voigt LF; Beresford SA
Int J Cancer; 1997 Jan; 70(3):278-81. PubMed ID: 9033627
[TBL] [Abstract][Full Text] [Related]
17. Menstrual and reproductive factors in relation to risk of endometrial cancer in Chinese women.
Wernli KJ; Ray RM; Gao DL; De Roos AJ; Checkoway H; Thomas DB
Cancer Causes Control; 2006 Sep; 17(7):949-55. PubMed ID: 16841262
[TBL] [Abstract][Full Text] [Related]
18. Reversible contraception for the woman over 35 years of age.
Archer DF
Curr Opin Obstet Gynecol; 1992 Dec; 4(6):891-6. PubMed ID: 1450355
[TBL] [Abstract][Full Text] [Related]
19. Results of oral contraceptive epidemiologic studies regarding neoplastic and cardiovascular effects.
Grimes DA
Int J Fertil; 1989; 34 Suppl():27-33. PubMed ID: 2576254
[TBL] [Abstract][Full Text] [Related]
20. Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk.
Maxwell GL; Schildkraut JM; Calingaert B; Risinger JI; Dainty L; Marchbanks PA; Berchuck A; Barrett JC; Rodriguez GC
Gynecol Oncol; 2006 Nov; 103(2):535-40. PubMed ID: 16740300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
